Ahluwalia B, Moraes L, Magnusson MK, Öhman L (2018) Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies. Scand J Gastroenterol 53(4):379–389
Ananthakrishnan AN (2015) Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol 12(4):205–217
Asensi V, Valle E, Meana A, Fierer J, Celada A, Alvarez V, Paz J, Coto E, Carton JA, Maradona JA (2004) In vivo interleukin-6 protects neutrophils from apoptosis in osteomyelitis. Infect Immun 72(7):3823–3828
CAS PubMed PubMed Central Article Google Scholar
Atreya R, Mudter J, Finotto S, Müllberg J, Jostock T, Wirtz S, Schütz M, Bartsch B, Holtmann M, Becker C (2000) Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat Med 6(5):583–588
CAS PubMed Article Google Scholar
Atreya R, Neurath M (2008) New therapeutic strategies for treatment of inflammatory bowel disease. Mucosal Immunol 1(3):175–182
CAS PubMed Article Google Scholar
Barnes TC, Anderson ME, Moots RJ (2011) The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis. Int J Rheumatol. https://doi.org/10.1155/2011/721608
Article PubMed PubMed Central Google Scholar
Becker C, Dornhoff H, Neufert C, Fantini MC, Wirtz S, Huebner S, Nikolaev A, Lehr H-A, Murphy AJ, Valenzuela DM (2006) Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis. J Immunol 177(5):2760–2764
CAS PubMed Article Google Scholar
Beltrán CJ, Núñez LE, Díaz-Jiménez D, Farfan N, Candia E, Heine C, López F, González MJ, Quera R, Hermoso MA (2010) Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease. Inflamm Bowel Dis 16(7):1097–1107
Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441(7090):235–238
CAS PubMed Article Google Scholar
Boe A, Baiocchi M, Carbonatto M, Papoian R, Serlupi-Crescenzi O (1999) Interleukin 6 knock-out mice are resistant to antigen-induced experimental arthritis. Cytokine 11(12):1057–1064
CAS PubMed Article Google Scholar
Borghini R, Vescovo M, Giordano C, Donato G, Picarelli A (2021) Onset of suspected ulcerative colitis after treatment with tocilizumab in patient with celiac disease and juvenile idiopathic arthritis. Inflamm Bowel Dis 27(6):e76–e78
Bouguen G, Chevaux J-B, Peyrin-Biroulet L (2011) Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases. World J Gastroenterol: WJG 17(5):547
CAS PubMed PubMed Central Article Google Scholar
Bradham C, McClay DR (2006) p38 MAPK in development and cancer. Cell Cycle 5(8):824–828
CAS PubMed Article Google Scholar
Bray SJ (2006) Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7(9):678–689
CAS PubMed Article Google Scholar
Brzozowski B, Mazur-Bialy A, Pajdo R, Kwiecien S, Bilski J, Zwolinska-Wcislo M, Mach T, Brzozowski T (2016) Mechanisms by which stress affects the experimental and clinical inflammatory bowel disease (IBD): role of brain-gut axis. Curr Neuropharmacol 14(8):892–900
CAS PubMed PubMed Central Article Google Scholar
Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, Powrie F (2010) Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464(7293):1371–1375
CAS PubMed PubMed Central Article Google Scholar
Cai J, Zhang N, Zheng Y, De Wilde RF, Maitra A, Pan D (2010) The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev 24(21):2383–2388
CAS PubMed PubMed Central Article Google Scholar
Caiello I, Minnone G, Holzinger D, Vogl T, Prencipe G, Manzo A, De Benedetti F, Strippoli R (2014) IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases. PLoS ONE 9(10):e107886
PubMed PubMed Central Article CAS Google Scholar
Calabrese LH, Rose-John S (2014) IL-6 biology: implications for clinical targeting in rheumatic disease. Nat Rev Rheumatol 10(12):720–727
CAS PubMed Article Google Scholar
Cao J, Zhang H, Yang Z, Zhao J, Ma H (2020) Effect of dehydroepiandrosterone on the immune response and gut microbiota in dextran sulfate sodium-induced colitis mice. Mol Immunol 118:60–72
CAS PubMed Article Google Scholar
Cao Q, Lin Y, Yue C, Wang Y, Quan F, Cui X, Bi R, Tang X, Yang Y, Wang C (2021) IL-6 deficiency promotes colitis by recruiting Ly6Chi monocytes into inflamed colon tissues in a CCL2-CCR2-dependent manner. Eur J Pharmacol 904:174165
CAS PubMed Article Google Scholar
Chen W, Yuan H, Cao W, Wang T, Chen W, Yu H, Fu Y, Jiang B, Zhou H, Guo H (2019) Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation. Theranostics 9(14):3980
CAS PubMed PubMed Central Article Google Scholar
Chen Y, Chen H, Ding J, Stanton C, Ross RP, Zhao J, Zhang H, Yang B, Chen W (2021) Bifidobacterium longum ameliorates dextran sulfate sodium-induced colitis by producing conjugated linoleic acid, protecting intestinal mechanical barrier, restoring unbalanced gut Microbiota, and regulating the toll-like receptor-4/Nuclear Factor-κB signaling pathway. J Agric Food Chem 69(48):14593–14608
CAS PubMed Article Google Scholar
Choi JS, Kim K-H, Lau LF (2015) The matricellular protein CCN1 promotes mucosal healing in murine colitis through IL-6. Mucosal Immunol 8(6):1285–1296
CAS PubMed PubMed Central Article Google Scholar
Chonov DC, Ignatova MMK, Ananiev JR, Gulubova MV (2019) IL-6 activities in the tumour microenvironment. Part 1. Open Access Macedonian J Med Sci 7(14):2391
Clarke WT, Feuerstein JD (2019) Colorectal cancer surveillance in inflammatory bowel disease: practice guidelines and recent developments. World J Gastroenterol 25(30):4148
PubMed PubMed Central Article Google Scholar
Coskun M, Vermeire S, Nielsen OH (2017) Novel targeted therapies for inflammatory bowel disease. Trends Pharmacol Sci 38(2):127–142
CAS PubMed Article Google Scholar
Dai Y, Jiao H, Teng G, Wang W, Zhang R, Wang Y, Hebbard L, George J, Qiao L (2014) Embelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signaling. Mol Cancer Ther 13(5):1206–1216
CAS PubMed Article Google Scholar
Danese S, Vermeire S, Hellstern P, Panaccione R, Rogler G, Fraser G, Kohn A, Desreumaux P, Leong RW, Comer GM (2019) Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II). Gut 68(1):40–48
CAS PubMed Article Google Scholar
De Souza HS, Fiocchi C (2016) Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol 13(1):13–27
PubMed Article CAS Google Scholar
Deiana M, Serra G, Corona G (2018) Modulation of intestinal epithelium homeostasis by extra virgin olive oil phenolic compounds. Food Funct 9(8):4085–4099
CAS PubMed Article Google Scholar
Deng J, Zhao L, Yuan X, Li Y, Shi J, Zhang H, Zhao Y, Han L, Wang H, Yan Y (2022) Pre-administration of berberine exerts chemopreventive effects in aom/dss-induced colitis-associated carcinogenesis mice via modulating inflammation and intestinal microbiota. Nutrients 14(4):726
CAS PubMed PubMed Central Article Google Scholar
Devaraj S, Hemarajata P, Versalovic J (2013) The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin Chem 59(4):617–628
CAS PubMed PubMed Central Article Google Scholar
Diehl SA, Schmidlin H, Nagasawa M, Blom B, Spits H (2012) IL-6 triggers IL-21 production by human CD4+ T cells to drive STAT3-dependent plasma cell differentiation in B cells. Immunol Cell Biol 90(8):802–811
CAS PubMed PubMed Central Article Google Scholar
Dimitrov S, Lange T, Benedict C, Nowell MA, Jones SA, Scheller J, Rose-John S, Born J, Dimitrov S, Lange T (2006) Sleep enhances IL-6 trans-signaling in humans. FASEB J 20(12):2174–2176
CAS PubMed Article Google Scholar
Dinarello CA (1999) IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 103(1):11–24
CAS PubMed Article Google Scholar
Dinarello CA (2009) Interleukin-1β and the autoinflammatory diseases. Mass Medical Soc 360:2467–2470
留言 (0)